Abstract
Transcription activator-like effector nucleases (TALENs) are powerful tools for gene editing, yet their application in organ-specific in vivo studies has faced significant hurdles. This study presents a modified TALEN strategy that utilizes a dual-fluorescence reporter system and unilateral nephrectomy to generate kidney-specific Ttc36 knockout mice. This approach allows for rapid genotype and phenotype validation in founder (F0) mice within 11 weeks, reaching stable heterozygous offspring by 17 weeks, without compromising reproductive capacity or the inheritability of the mutation.
Introduction
Functional genomics in mice traditionally relies on embryonic stem (ES) cell targeting, a process that is notoriously slow, expensive, and labor-intensive. While newer gene-editing tools like TALENs have accelerated systemic knockouts, studying organ-specific development—particularly in the kidney—remains a bottleneck. Typically, researchers must breed founder (F0) mice to the F1 or F2 generation to confirm a successful knockout and observe the resulting phenotype, adding months to the experimental timeline. This study introduces a modified workflow designed to validate knockouts directly in founder mice while ensuring they remain viable for breeding.
Methodology
The researchers introduced three key modifications to the standard TALEN workflow to enhance efficiency and speed:
- Dual-Fluorescence Reporter System: Before embryo injection, TALEN activity was validated in vitro using HEK293FT cells. The system employed a plasmid with a disrupted ZsGreen gene and a functional tdTomato gene. Successful TALEN cleavage followed by homologous recombination restored the ZsGreen gene, causing cells to fluoresce green. Red fluorescence from tdTomato served as a transfection control, allowing for precise quantification of TALEN efficiency.
- Optimized Microinjection: The study compared traditional pronuclear microinjection with cytoplasmic microinjection of TALEN mRNA into one-cell embryos. Cytoplasmic injection proved significantly more efficient, yielding an 85.7% mutagenesis rate compared to 30.4% for pronuclear injection.
- Unilateral Nephrectomy (Live Biopsy): At six weeks of age, founder (F0) mice underwent surgery to remove one kidney. This "live biopsy" enabled immediate molecular analysis—including DNA sequencing, RT-PCR, Western blotting, and immunofluorescence—to confirm the knockout in the target organ before the mice were bred.
Key Results
- Mutagenesis Efficiency: The modified strategy achieved an average mutagenesis efficiency of 51.3% in knockout mice.
- Accelerated Timeline: The entire process, from TALEN construction to obtaining preliminary data from the F0 kidney, took only 11 weeks. Stable heterozygous offspring were obtained by 17 weeks, significantly faster than traditional 18+ week benchmarks.
- Molecular Confirmation of Ttc36: The study confirmed that the Ttc36 protein is localized specifically to the renal proximal tubules. In homozygous knockouts, this protein was entirely absent, validating Ttc36 as a reliable marker for this kidney structure.
- Inheritability: Sequencing of F1 offspring confirmed that TALEN-induced mutations were stably inherited through the germline, and the unilateral nephrectomy did not impair the founders' ability to reproduce.
Discussion and Limitations
While highly efficient, the authors noted that cytoplasmic injections can lead to mosaicism, where different tissues in the founder mouse possess different genotypes. Although unilateral nephrectomy confirms the mutation in the kidney, breeding remains necessary to produce non-mosaic homozygous lines for long-term study.
This strategy was developed as CRISPR/Cas9 technology was emerging. While CRISPR offers even higher targeting efficiency, the "live biopsy" screening approach via unilateral nephrectomy remains a valuable technique for accelerating phenotype validation in kidney research. Future work will focus on applying this screening strategy to CRISPR-based models and performing deeper multi-omic analyses on the collected kidney samples.
Summary updated